author-photo

Eva Galizia

Marche Polytechnic University

62

Papers

1177

Citations

Citation Trend

Filter By

Papers (39) Sort By

Journal Conference Others

Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study (Targeted Oncology, (2020), 15, 1, (115-126), 10.1007/s11523-020-00698-x)

2020 Targeted Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study

2020 Targeted Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies

2019 Expert Review of Cardiovascular Therapy
Show All
- Source
- Cite
- Save
Citations (0)
CARAMEL study: Clinical prognostic biomarkers for ipilimumab-related outcome in metastatic melanoma patients

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Correlation of activated AKT and MAPK expression in liver metastases with clinical outcome in colorectal cancer patients receiving irinotecan/cetuximab treatment.

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Role of Vascular Endothelial Growth Factor (VEGF) and VEGF-R Genotyping in Guiding the Metastatic Process in pT4a Resected Gastric Cancer Patients

2012 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (13)
Prognostic Significance of EGFR, HER-2, CEA on Circulatingtumour Cells (CTCS) in Patients with Metastatic Non-Small-Cell Lung Cancer (MNSCLC)

2012 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan–cetuximab

2012 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (30)
Pretreatment levels of serum lactate dehydrogenase (LDH) and clinical outcome in metastatic colorectal cancer patients receiving first-line chemotherapy and bevacizumab.

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Tumor angiogenesis as predictive factor for site of relapse in patients with gastric cancer: Biological and clinical implications.

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)